Skip to main content

Table 4 Final T and N stages of the cases in the upfront surgery group detected by different imaging modalities

From: The additive role of dynamic contrast-enhanced and diffusion-weighted MR imaging in preoperative staging of breast cancer

Size (T)

SM

DCE-MRI

MRI-DWI

Pathology

Tx

3/37 (8.1%)

0/37

0/37

0/37

T0

4/37 (10.8%)

1/37 (2.7%)

14/37 (37.8%)

1/37 (2.7%)

T1

9/37 (24.3%)

7/37 (18.9%)

7/37 (18.9%)

13/37 (35.1%)

T2

18/37 (48.6%)

20/37 (54%)

8/37 (21.6%)

16/37 (43.2%)

T3

3/37 (8.1%)

9/37 (24.3%)

8/37 (21.6%)

6/37 (16.2%)

T4

0/37

0/37

0/37

1/37 (2.7%)

Lymph node (N)

SM

DCE-MRI

MRI-DWI

Pathology

Nx

3/37 (8.1%)

8/37(21.6%)

0/37

0/37

N0

22/37 (59.4%)

17/37 (45.9%)

24/37 (64.8%)

22/37 (59.4%)

N1

11/37 (29.7%)

10/37 (27%)

11/37 (29.7%)

11/37 (29.7%)

N2

1/37 (2.7%)

1/37 (2.7%)

1/37 (2.7%)

3/37 (8.1%)

N3

0/37

1/37 (2.7%)

1/37 (2.7%)

1/37 (2.7%)